Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer
Minna Sopo,Maarit Anttila,Kirsi Hämäläinen,Annukka Kivelä,Seppo Ylä-Herttuala,Veli-Matti Kosma,Leea Keski-Nisula,Hanna Sallinen
DOI: https://doi.org/10.1186/s12885-019-5757-3
IF: 4.638
2019-06-14
BMC Cancer
Abstract:<h3 class="Heading">Background</h3><p class="Para">In many malignancies including ovarian cancer, different angiogenic factors have been related to poor prognosis. However, data on their relations to each other or importance as a prognostic factor in ovarian cancer is missing. Therefore, we investigated the expressions of VEGF-A, VEGF-C, and VEGF-D, and the receptors VEGFR1, VEGFR2, and VEGFR3 in patients with malignant epithelial ovarian neoplasms. We further compared expression levels between primary tumors and related distant omental metastases.</p><h3 class="Heading">Methods</h3><p class="Para">This study included 86 patients with malignant ovarian epithelial tumors and 16 related distant metastases. Angiogenic factor expression was evaluated using immunohistochemistry (<em class="EmphasisTypeItalic">n</em> = 102) and qRT-PCR (<em class="EmphasisTypeItalic">n</em> = 29).</p><h3 class="Heading">Results</h3><p class="Para">Compared to primary high grade serous ovarian tumors, the related omental metastases showed higher expressions of VEGF-A (<em class="EmphasisTypeItalic">p</em> = 0.022), VEGF-D (<em class="EmphasisTypeItalic">p</em> = 0.010), and VEGFR1 (<em class="EmphasisTypeItalic">p</em> = 0.046). In univariate survival analysis, low epithelial expression of VEGF-A in primary tumors was associated with poor prognosis (<em class="EmphasisTypeItalic">p</em> = 0.024), and short progression-free survival was associated with high VEGF-C (<em class="EmphasisTypeItalic">p</em> = 0.034) and low VEGFR3 (<em class="EmphasisTypeItalic">p</em> = 0.002). The relative expressions of VEGF-D, VEGFR1, VEGFR2, and VEGFR3 mRNA determined by qRT-PCR analyses were significantly correlated with the immunohistochemically detected levels of these proteins in primary high grade serous ovarian cancer and metastases (<em class="EmphasisTypeItalic">p</em> = 0.004, <em class="EmphasisTypeItalic">p</em> = 0.009, <em class="EmphasisTypeItalic">p</em> = 0.015, and <em class="EmphasisTypeItalic">p</em> = 0.018, respectively).</p><h3 class="Heading">Conclusions</h3><p class="Para">The expressions of VEGF receptors and their ligands significantly differed between malignant ovarian tumors and paired distant metastases. VEGF-A, VEGF-D, and VEGFR1 protein expressions seem to be higher in distant metastases than in the primary high grade serous ovarian cancer lesions.</p>
oncology